The global cell dissociation market size is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7% during the forecast period. The growth in this market is attributed to the prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies. Moreover, the growth opportunities in emerging markets are expected to provide growth opportunities for players in the cell dissociation market during the forecast period.
Enzymatic dissociation products segment to witness the highest growth during the forecast period. Based on the product, the cell dissociation market is segmented into Enzymatic dissociation products, Non-Enzymatic dissociation products and instruments.The Enzymatic dissociation products segment is projected to grow at the highest CAGR during the forecast period.
The large share of this segment can be attributed increasing incidence of cell based research is the major factor supporting the growth of this segment.
Connective tissue segment to register the highest growth in the cell dissociation market during the forecast period. Based on the tissue, the cell dissociation market is segmented into connective tissues, epethilial tissues and other tissues (skeletal, muscles tissues).The connective tissues segment is projected to witness the highest growth in the cell dissociation market during the forecast period.
The large share of this segment can be attributed to cell based research and development in pharmaceutical and biotechnology companies.
Asia Pacific is estimated to register the highest CAGR during the forecast period. In this report, the cell dissociation market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).The market in Asia Pacific is projected to register the highest growth rate during the forecast period.
The growth in this market is primarily driven by The increasing fundind for cell based research .
Breakdown of supply-side primary interviews, by company type, designation, and region: • By Company Type: Tier 1 (32%) , Tier 2 (44%), and Tier 3 (24%) • By Designation: C-level (30%), Director-level (34%), and Others (36%) • By Region: North America (40%), Europe (28%), AsiaPacific (20%), and Rest of the World(12%)
List of Companies Profiled in the Report • Thermo Fisher Scientific (US) • Becton, Dickinson and Company (US) • Roche Diagnostics (Switzerland) • Cytiva (a part of Danaher Corporation) (US) • STEMCELL Technologies (Canada) • Miltenyi Biotec (Germany) • PromoCell GmbH (Germany) • AcceGen(US), VitaCyte (US) • Alstem (US) • Biological Industries (Israel) • Gemini Bio (US) • Innovative Cell Technologies (US) • Central Drug House (India) • Worthington Biochemical Corporation (US) • Capricorn Scientific (Germany) • Abeomics (US) • Genlantis (US) • Neuromics (US)
Research Coverage This report studies the cell dissociation market based on product, technology, application, end user, and region.The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell dissociation market.
The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers: • Market Penetration: Comprehensive information on cell dissociation products offered by the top 27 players in the cell dissociation market. The report analyzes the cell dissociation market by product, tissue, type, end user, and region. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions. • Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the cell dissociation market • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cell dissociation market
Our reports have been used by over 10K customers, including:
The global custom antibody market is projected to reach USD 652 million by 2026 from USD 393 million in 2021, at a CAGR of 10.6% during the forecast period.The increasing demand for protein therapeutics is expected to drive the custom antibody market in the coming years. On the other hand, the need for significant capital investments and long...
The chromatography resin market size is estimated to be USD 2.2 billion in 2020 and is projected to reach USD 3.3 billion by 2025, at a CAGR of 8.2% between 2020 and 2025. Factors such as increasing demand for therapeutic antibodies, public-private investment in pharmaceutical & life science research, and rising concern for food safety will...
The cell-free protein expression market is expected to register a CAGR of nearly 6.1%, during the forecast period, 2019-2024. - The major factors for the growth of the cell-free protein expression market include the increasing R&D in the fields of proteomics and genomics, high prevalence of cancer and infectious diseases, and shorter-expression...
The global flow imaging microscopy market size is projected to reach USD 45 million by 2025 from USD 32 million in 2020, at a CAGR of 7.4%. The growth of the market is attributed to increasing investment in the field of nanotechnology, growing investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across...
102 pages •
By Asia Market Information & Development Company
• Apr 2021
This study focuses on China’s Biotechnology industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers...
Shot in the arm: Work on COVID-19 antibody tests and vaccines is supporting current-year growth Abstract Biotechnology in the UK Biotechnology uses scientific principles to create technological applications that use biological systems, living organisms or derivatives thereof to make or modify products...
The global pyrogen testing market size is projected to reach USD 1,689 million by 2025 from USD 927 million in 2020, at a CAGR of 12.7% during the forecast period. Market growth is driven by factors such as the rising incidence of infectious diseases and increasing pandemics frequency, increasing R & D in the pharmaceutical and biotechnology...
The global human organoids market size is projected to reach USD 1,901 million by 2025 from USD 850 million in 2020, at a CAGR of 17.5%. Factors such as the technological advancements in the market are propelling the growth of the human orgnaoids market. Additionally, rising cases of transplants, investments from both private and public sectors...
The chiral chromatography columnmarketsize is projected to reach USD 123 million by 2025 from an estimated USD 99 million in 2020, at a CAGR of4.5% during the forecast period. Increasing R&D investments in the pharmaceutical and biotechnology industry is creating demand opportunities for the chiral chromatography column industry. Also,increasing...
The global mycoplasma testing market size is valued at an estimated USD 689 million in 2020 and is projected to reach USD 1,095 million by 2025, at a CAGR of 9.7% during the forecast period. The global mycoplasma testing industry’s growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.